- •Acknowledgment
- •Abbreviations and Glossary
- •Contents
- •Introduction
- •1: Should You Become a VR Surgeon?
- •2.2 A Word of Caution
- •Introduction
- •3: Fundamental Rules for the VR Surgeon
- •3.4 The “What, When, How – and Why” Questions
- •3.5 Don’t Start What You Cannot Finish
- •3.6 Common Sense vs Dogma
- •3.7 Maximal Concentration During the Entire Operation
- •3.8 Make Life as Easy for Yourself as Possible
- •3.9 Under Peer Pressure: To Yield or Not to Yield
- •3.10 Referral of the Patient
- •3.11 The Rest of the Eyeball…
- •4.1 What If the Surgeon Has Tremor?
- •4.2 How Important Is Good Dexterity?
- •4.5 Combined Surgery or Cataract Surgery Separately?
- •4.7 How Much Confidence in Himself Should the VR Surgeon Have?
- •4.8 How Long Do Vitrectomies Take?
- •4.9 Was Surgery Successful?
- •5.1 The “Target” of Counseling
- •5.2 The Patient Does Not Know Most of What Is so Obvious to the Surgeon
- •5.3 Communicating with the Patient
- •5.4 Coaching vs Trying to Be Objective
- •5.5 The Ultimate Treatment Decision: “Whose Eye Is It?”
- •5.6 Which of the Two Eyes to Operate on First?
- •5.7 What if the Eye Has Two Diseases?
- •5.8 What if the Eye Has Severe Visual Loss and the Chance of Improvement with Another Surgery Is Low?
- •5.9 Empathy: The Single Most Important Component of Counseling
- •5.10 The Prognosis with the Chosen Surgical Option
- •5.11 If the Patient Chooses to Undergo Surgery
- •5.12 The Benefits of Proper Counseling
- •5.14 The Dogmas
- •6: The VR Surgeon’s Relation to His Nurse
- •7: Examination
- •8: The Indication Whether to Operate
- •8.1 The Argument in Favor of Surgery
- •8.3 The Age of the Patient
- •8.4 The Condition of the Fellow Eye
- •11: The Surgeon’s Relation to Himself
- •11.3 Self-Examination
- •Introduction
- •12.1.1 The Pump
- •12.1.1.1 Peristaltic Pump: Flow Control
- •12.1.2 The Probe
- •12.1.2.2 Port Location
- •12.1.2.3 Port Configuration and Size
- •12.1.2.4 Cut Rate
- •12.1.2.6 Probe Length
- •12.1.3 The Light Source/Pipe
- •12.1.4 The Infusion Supply
- •12.1.5 The Trocar
- •12.1.6 The Cannula
- •12.1.7 System to Inject/Extract Viscous Fluid
- •12.1.8 The Pedal
- •12.1.10 Endodiathermy Probe
- •12.1.11 The User Interface of the Vitrectomy Console
- •12.1.12 Troubleshooting
- •12.2 The Microscope
- •13: Instruments, Tools, and Their Use
- •13.2.1.1 General Concepts of Working with Squeezable Instruments
- •13.2.1.2 The Handle
- •13.2.1.3 Forceps
- •13.2.1.4 Scissors
- •13.2.2 Hybrid Instruments
- •13.2.2.2 Retractable Instruments
- •13.2.3 Non-squeezable Hand Instruments
- •13.2.3.1 Bent (Hooked, Barbed) Needle
- •13.2.3.2 Membrane Scraper
- •13.2.3.3 Spatula/Pic
- •13.2.3.4 Intraocular Magnet
- •13.3.1 Membrane Dissection (“Viscosurgery”): Viscoelastics as a Spatula
- •13.3.2 Opening a Closed Funnel
- •14: Materials and Their Use
- •14.2 Intravitreal Gas
- •14.3 Silicone Oil
- •14.3.1 Types of Silicone Oil
- •14.3.3 Complications Related to Silicone Oil Use
- •14.3.4 Complications Related to Silicone Oil Use Removal
- •14.4 PFCL
- •14.6 Sutures
- •15: Anesthesia
- •15.1 How to Decide the Type of Anesthesia
- •15.2 If Local Anesthesia Is Chosen
- •15.3 Medications If Local Anesthesia Is Used
- •16: The Surgeon at the Operating Table
- •16.1 The OR Personnel
- •16.2 The Operating Table and the Surgeon’s Chair
- •16.2.1 The Operating Table
- •16.2.2 The Surgeon’s Chair
- •16.4 The Microscope
- •16.5 The BIOM
- •16.5.1 BIOM: The Advantages
- •16.5.2 BIOM Use: Practical Information
- •16.5.3 BIOM: Setting Up for Daily Use
- •16.5.4 BIOM: Checklist
- •16.5.5 BIOM: Troubleshooting
- •16.6 The Patient
- •16.7 The Surgeon
- •16.7.2 At the Start of Vitrectomy
- •16.7.3 Staring into the Microscope
- •16.8 Music in the OR
- •16.9 The Brightness in the OR
- •16.10 The Quality of the Air in the OR
- •16.12 The Blueprint of the OR
- •16.13 The Captain in the OR
- •16.14 The Fundamental Technical Rules of Performing Intravitreal Surgery
- •Introduction
- •17.3 The Endoscope Approach (EAV)
- •17.4 Portable Systems
- •17.5 3D Viewing
- •18.1 Disinfection and Draping
- •18.2 The Monocular Patient
- •18.3 At the Conclusion of the Operation
- •19: The Speculum and Its Placement
- •19.1 General Considerations
- •19.2 Speculum Placement
- •20.3 Injecting into the Vitreous Cavity During Surgery
- •21: Sclerotomies and the Cannulas
- •21.2 Location of the Sclerotomies
- •21.2.1 Distance from the Limbus
- •21.2.2 Location in Clock Hours
- •21.2.3 In Case of a Reoperation
- •21.2.4 In Case of Scleral Thinning
- •21.3 Inserting the Cannula
- •21.4 The Order of Cannula Placement
- •21.5 If the Palpebral Opening Is Small
- •21.6 Checking the (Infusion) Cannula
- •21.6.1 Cannula Under the Choroid/Retina: Prevention
- •21.6.2 Cannula Under the Choroid/Retina: Management
- •21.6.3 Infusion Going Under the Choroid/Retina: Management
- •21.7 The Cannulas in Use
- •21.8 The Removal of the Cannulas
- •21.8.1 Hypotony: The Causes
- •21.8.2 Hypotony: The Consequences
- •21.8.3 Hypotony: Prevention
- •21.8.4 Hypotony: Postoperative Management
- •22: Illumination
- •22.1 The Light Pipe
- •22.3 Light Built into the Handheld Instruments
- •24: Using the Vitrectomy Probe
- •24.1 Removal of the Vitreous
- •24.2 Removal of Proliferative Membranes
- •24.3 Removal of the Retina
- •24.4 Removal of the Lens
- •25: Maintaining Good Visualization
- •25.1.1 The Microscope
- •25.1.2 The Contact Lens
- •25.1.3 The Corneal Surface
- •25.1.4 The Corneal Stroma
- •25.2 Internal Factors
- •25.2.2 Pupil
- •25.2.2.1 Mechanical Forces Preventing Pupil Dilation
- •25.2.2.2 Intracameral Adrenalin or Visco
- •25.2.2.4 Iris Ring
- •25.2.2.5 Iridotomy
- •25.2.3 Lens
- •25.2.3.1 Cataract
- •25.2.3.2 “Feathering”
- •25.2.3.3 “Gas Cataract”
- •25.2.3.4 “Lens Touch”
- •25.2.4.1 Phimosis of the Anterior Capsule
- •25.2.4.2 Deposit on the Anterior IOL Surface
- •25.2.4.3 Problems with the IOL Itself
- •25.2.4.4 Fluid Condensation
- •25.2.5 The Posterior Capsule
- •25.2.6 The Vitreous Cavity
- •25.2.7 Epiretinal (Subhyaloidal) Materials
- •25.2.7.1 Blood
- •25.2.8 The Surgeon’s Actions
- •25.2.9 “Chromovitrectomy”
- •26.1.1 Vitreous Macroanatomy
- •26.1.2 Vitreous Biochemistry and Its Anatomical and Functional Implications
- •26.1.3 Retinal Histology and Macroanatomy
- •26.1.4 Anterior Segment Dimensions
- •26.2 External Anatomy for the VR Surgeon
- •26.3 Physiology: What Keeps the Retina Attached?
- •26.3.1 The RPE Pump
- •26.3.3 Presence of the Vitreous Gel
- •27: The Basics of Vitreous Removal
- •27.1 The Rationale for PPV
- •27.2 How Much Vitreous to Remove?
- •27.3 Recognizing the Presence of the Vitreous Gel
- •27.3.1 Mechanical Aids
- •27.3.2 Air (Pneumovitrectomy)
- •27.3.3 Stains and Markers
- •27.4 The Sequence of Vitreous Removal
- •27.5.2 Vitrectomy Anterior to the Equator
- •27.5.3 Vitrectomy Behind the Lens
- •28: Scleral Indentation
- •28.1 The Advantages of Scleral Indentation
- •28.2 The Mechanics of Vitrectomy with Scleral Indentation
- •28.3 Internal vs External Illumination
- •28.5 External Illumination and Nurse Indentation
- •28.6 Instrumentation and Technique
- •29: Cryopexy
- •29.1 Indication in RD
- •29.2 Surgical Technique
- •29.3 Cryopexy as a Destructive Force
- •30: Endolaser
- •30.1 The Consequences of Laser Treatment
- •30.2 The Setup
- •30.3 The Technique of Endolaser Treatment
- •30.3.1 General Considerations
- •30.3.2 Panretinal Treatment
- •30.3.3 Endolaser Cerclage and Its Complications
- •30.3.4 Endolaser as a Walling-Off (Barricading) Tool
- •30.3.5 Endolaser as a Welding Tool
- •30.4 Peripheral Laser and the Beginner VR Surgeon
- •30.5 Endocyclophotocoagulation
- •30.6 Laser Cerclage at the Slit Lamp
- •31: Working With and Under Air
- •31.1.1 Attached Retina
- •31.3 The Utilization of an Air Bubble
- •32: Working with Membranes
- •32.1.1 Instrumentation and Infrastructure
- •32.1.2 Opening the ILM
- •32.1.2.1 Sharp Opening: Incision First
- •32.1.2.2 Blunt Opening: No Incision
- •The Scraper
- •32.1.3 Peeling the Membrane
- •32.1.4 The Extent of ILM Peeling
- •32.1.5 What If the ILM Cannot Be Peeled?
- •32.1.6 ILM Removal in Eyes with Detached Macula
- •32.1.6.1 Reattaching the Macula First
- •32.1.6.2 Peeling When the Macula Is Still Detached
- •32.2.2 Removal Technique
- •32.2.2.1 Staining or Not?
- •32.2.2.2 Instrumentation
- •32.2.2.3 Location of the Point of Attack
- •32.2.2.4 The Major Risks When First Grabbing an EMP
- •32.2.2.5 The Direction of Peeling: Centripetal vs Centrifugal
- •32.2.2.6 The Speed of Peeling
- •32.2.2.7 The Extent of Peeling
- •32.2.2.8 ILM Peeling
- •32.2.2.9 Completion of Surgery
- •32.3.1.1 Recognition
- •32.3.1.2 The Goals of Surgery
- •32.3.1.3 Instrumentation
- •32.3.1.4 Surgical Steps
- •32.3.1.5 Closed Funnel/Retinal Incarceration
- •32.3.1.6 ILM Removal
- •32.4 Subretinal Membranes/Strands
- •33.1 Retinectomy
- •34: Chromovitrectomy
- •34.1 Posterior Vitreous Cortex
- •34.3.1 False-Positive Staining with ICG
- •34.3.2 Injection Technique for Staining the ILM
- •34.4 Newly Formed (PVR) Membranes
- •35: Tamponades
- •35.2 Gases
- •35.2.1 General Considerations
- •35.2.3 Gas Injection into the Nonvitrectomized Eye
- •35.2.4 The Eye with Gaseous Tamponade
- •35.3.1 Indications to Use Heavier-Than-Water Liquids
- •35.3.2 Surgical Technique
- •35.3.2.1 Implantation
- •35.4 Silicone Oil
- •35.4.1 Selecting the Type of Silicone Oil to Implant
- •35.4.2 General Considerations
- •35.4.3 Indications
- •35.4.3.1 Semipermanent Tamponade
- •35.4.3.2 Permanent Tamponade
- •35.4.4 Implantation
- •35.4.5 With Silicone Oil in the Eye
- •35.4.5.1 General Considerations
- •35.4.5.2 Emulsification
- •35.4.6 Removal
- •35.4.6.1 Timing
- •35.4.6.2 Surgical Technique
- •35.5 Exchanges
- •35.6 If the Eye Is Aphakic
- •36: Submacular Hemorrhage
- •36.1 The Nonsurgical Approach: Intravitreal Gas and tPA
- •36.2 Removal of the Clot In Toto
- •36.4 The Minimalistic Surgical Approach
- •37: Subretinal Biopsy
- •38: Combined Surgery
- •38.1 Phacoemulsification
- •38.2 Lensectomy
- •38.2.1 Lens In Situ
- •38.3.1 Lens In Situ
- •38.3.2 Lens in Vitreous
- •38.4.2 No IOL Implantation
- •38.5 Capsule Removal
- •38.5.1 Indications
- •38.5.2 Surgical Technique
- •38.6.1 Advantages
- •38.6.2 Surgical Technique
- •38.6.3 Subsequent Sub/luxation of an Iris-Claw IOL
- •38.6.3.1 Subluxated Lens
- •38.6.3.2 Luxated Lens
- •39: AC Basics
- •39.1 Paracentesis
- •39.2 Iris Prolapse
- •39.3 Anterior Synechia
- •39.5 Material in the AC
- •40.2 Retinal Tear
- •40.3 Reopening of a Posterior Scleral Wound
- •40.4 Lens/IOL Trauma
- •41: Pediatric Patients
- •42: The Highly Myopic Eye
- •42.1 The Risk of RD If Cataract Surgery Is Needed
- •42.2 Vitrectomy in the Highly Myopic Eye
- •42.3 Posterior RD over a Staphyloma
- •43: Intravitreal Injections
- •Introduction
- •44: Dropped Nucleus and Dislocated IOL
- •44.1 General Considerations
- •44.1.2 Dislocated IOL
- •44.2 Surgical Technique
- •44.2.1 Dropped Nucleus
- •45: Endophthalmitis
- •45.1 General Considerations
- •45.1.1 Etiology
- •45.1.2 Clinical Diagnosis
- •45.1.3 Timing
- •45.1.4 Treatment Options and Management Philosophy
- •45.2 Surgical Technique
- •45.3 Posttraumatic Endophthalmitis
- •46: Floaters
- •46.1 General Considerations
- •46.1.1 Indication for Surgery
- •46.1.2 Timing of Surgery
- •46.2 Surgical Technique
- •47: Hyphema
- •47.1 General Considerations
- •47.1.1 The Rationale for Surgical Removal
- •47.1.2 Medical Treatment
- •47.2 Surgical Technique
- •47.2.1 Liquid Blood
- •47.2.1.1 Monomanual Technique
- •47.2.1.2 Bimanual Technique
- •47.2.2 Clotted Blood
- •48: Iris Abnormalities
- •48.1 General Considerations
- •48.1.2 Timing of Iris Reconstruction
- •48.2 Surgical Technique
- •48.2.2 Iridodialysis
- •48.2.3 Permanent Mydriasis
- •49: Macular Disorders: Edema
- •49.1 General Considerations
- •49.1.1 Etiology
- •49.1.2 Indications for Treatment: Surgical or Nonsurgical?
- •50.1 General Considerations
- •50.1.1 VMTS
- •50.1.2 Cellophane Maculopathy
- •50.1.3 Macular Pucker
- •50.1.4 Macular Hole
- •50.2.1 VMTS
- •50.2.2 Cellophane Maculopathy
- •50.2.3 Macular Pucker
- •50.2.4 Macular Hole
- •50.2.5 If Surgery Failed for a Macular Hole
- •51: Optic Pit
- •51.1 General Considerations
- •51.2 Surgical Technique
- •52.1 General Considerations
- •52.1.1 Indications
- •52.1.2 Preoperative Considerations
- •52.2 Surgical Technique
- •53.1 General Considerations
- •53.2 Surgical Technique
- •54: Retinal Detachment
- •54.1.1 RD Due to a Horseshoe or Giant Tear
- •54.1.2 RD Due to a Dialysis
- •54.1.3 RD Due to a Round Hole
- •54.1.4 RD Due to a Staphyloma
- •54.2 Additional Information About RD
- •54.2.1 History
- •54.2.3 Clinical Course
- •54.2.4 Using Laser to Prevent RD Development
- •54.2.4.1 Prophylaxis in the Affected Eye (RD, Current or Past)
- •54.2.4.2 Prophylaxis in the Fellow Eye
- •54.2.4.3 The Patient with a History of a Retinal Tear (No RD)
- •54.3 Treatment Principles
- •54.3.2 The Goals of Surgery
- •54.3.3 Prognosis
- •54.4.1 Preoperatively
- •54.4.2.1 Initial Steps
- •54.4.2.2 Creating a Chorioretinal Adhesion
- •54.4.2.3 Drainage of the Subretinal Fluid
- •54.4.2.5 Suturing
- •54.4.2.7 Adjusting the Buckle
- •54.4.2.8 Closing the Conjunctiva
- •54.4.2.9 Gas Tamponade
- •54.4.3 Major Intraoperative Complications of SB
- •54.5 Vitrectomy
- •54.5.2.3 Intraoperative Retinal Reattachment
- •54.5.2.4 Laser Retinopexy
- •54.5.2.5 Intraocular Tamponade
- •54.5.2.6 Postoperative Positioning
- •54.5.3 Follow-Up Visits
- •54.5.4 Prognosis
- •54.5.5 RD After Silicone Oil Removal
- •54.6 Pneumatic Retinopexy
- •54.6.1 General Considerations
- •54.6.2 Patient Selection
- •54.6.3 Surgical Options
- •54.6.3.1 Cryopexy, Followed by Gas Injection
- •54.6.3.2 Gas Injection, Followed by Laser
- •54.7 Reoperation
- •55: RD, Tractional and Combined
- •55.1.1 Characteristics of the RD
- •55.1.2 Management Principles
- •56: RD, Central
- •56.1 General Considerations
- •56.2 Surgical Technique
- •57: Retinoschisis
- •57.1.1 Anatomy and Pathophysiology
- •57.1.2 Prophylactic Laser Treatment
- •57.2 Surgical Technique
- •58.1 General Considerations
- •58.1.1 Treatment Options
- •58.1.2 The Vitrectomy Option
- •58.2 Surgical Technique
- •59: Scleroplasty
- •59.1 General Considerations
- •59.2 Surgical Technique
- •60: Suprachoroidal Hemorrhage
- •60.1.1 Indications for Surgery
- •60.1.2 Timing of Surgery
- •60.2 Surgical Technique
- •61: Uveitis, Posterior
- •62: Vitreous Hemorrhage
- •62.1 General Considerations
- •62.2 Surgical Technique
- •62.3 Severe Bleeding in a Young Patient
- •62.4 Rebleeding in a Vitrectomized Eye
- •63: Trauma
- •63.1 The Timing of Surgery
- •63.2 Contusion
- •63.3 Wound Toilette
- •63.5 Suturing the Sclera
- •63.6 Subluxated Lens
- •63.7 IOFB
- •63.7.2 Posterior Segment
- •63.8 Perforating Trauma and Ruptures
- •63.9 NLP and Sympathetic Ophthalmia
- •63.11 Hemorrhagic RD
- •63.12 Additional Considerations
- •64: Postoperative Care
- •Further Reading
- •Appendix
- •Part 2. Important Personal Experiences
Fundamental Rules for the VR Surgeon |
3 |
|
3.1Plan (Not Trial and Error)1
No VR surgeon should operate on a patient without first designing a plan, which is to be based on the characteristics of the condition in general and the characteristics of the condition in that specific person’s eye in particular.2 The plan involves three levels, the first two of which are strategic and the third tactical (see Table 3.1).
No VR surgeon should begin the treatment process without knowing three basic things:
•The condition of the eye at the onset – point A.3
•The expected condition of the eye at the termination of the intervention (the ideal, hoped-for outcome) – point B.
•How to get from point A to point B.
To sit down to the operating table and address each tissue pathology as it comes into view and deal with the technical challenges only as they emerge without first designing a plan is ineffective in its process and suboptimal in its outcome. Amazingly, the very surgeon who practices such a re-active type of surgery4 would never himself consider driving in an unfamiliar city from his current location (point A) to his destination (point B) without first consulting a map or GPS device to plan the route.
1As described in Chap. 5, all strategic decisions are to be made together with the patient.
2Behavioral economics provide an excellent example of the difference between reflective (auto- pilot-like) action vs one based on conscious consideration. Answer the following question: if the ball and the racquet together cost $11 and the racquet costs $10 more than the ball, how much does each cost? The reflective, rapidly given answer is $10 and $1; the considerate one says $10.50 and $0.50.
3This may be a very accurate diagnosis such as a visible macular hole or, less commonly, a vague one such as in an eye with a massive VH.
4“Let’s go step by step and see what happens.”
© Springer International Publishing Switzerland 2016 |
19 |
F. Kuhn, Vitreoretinal Surgery: Strategies and Tactics,
DOI 10.1007/978-3-319-19479-0_3
20 |
3 Fundamental Rules for the VR Surgeon |
|
|
Table 3.1 The three levels of planning in VR surgery |
|
Level |
Comment |
One: The strategy of the |
This is the most fundamental part of the plan: What number of |
entire treatment process |
surgeries appears to be ideal to allow reaching the most |
from the end of the |
optimal final outcome?a It may be preferable to forego a |
evaluation to the final |
comprehensive (all-in-one) reconstruction and instead choose a |
follow-up visit. |
staged approach with multiple surgeries. In the latter case (for |
Prevention of possible |
instance, for an eye with a severe rupture that caused lens |
complications is |
extrusion, vitreous hemorrhage, major retinal damage, and iris |
incorporated in the plan |
retraction), the surgeon must also develop a plan regarding the |
|
timing of each intervention. If a single surgery is sufficient to |
|
deal with the pathology,b planning on level one and level two |
|
merges into a single strategy, which includes the preoperative, |
|
perioperative, and postoperative medical treatment as well as |
|
the operation itself plus its timing |
Two: The strategy |
The surgeon should know what he intends to achieve during that |
concerning the |
particular surgery (see the text for more details). To close a |
upcoming operation. |
macular hole, for instance, the main surgical stepsc include |
Prevention of possible |
vitreous removal (with a preoperative decision regarding the |
complications is |
amount of vitreous to be removed; see Sect. 27.2), ILM |
incorporated in the plan |
peeling, and gas tamponade |
Three: This is the tactical |
The VR surgeon must make severald intraoperative decisions |
level. Prevention of |
related to the actual surgical technique (tissue tactics). Should |
intraoperative |
a proliferative membrane, for instance, be bluntly dissected or |
complications is |
sharply cut, and if the latter, whether with the probe or |
incorporated in the plan |
scissors, and if the latter, which type of scissors? Exactly |
|
where should the membrane be cut? At what angle should the |
|
scissors be held when the handle is finally squeezed? |
One to three: No part of the |
As the treatment progresses, whether it relates to strategy such as |
plan must be in stone |
staging and timing or tissue tactics such as the technique of |
|
ILM peeling, the surgeon must carefully observe how the |
|
tissue, the eyeball, and the person react to his actions (feedback |
|
on multiple levels). If the outcome of his activity differs from |
|
the expected,e he must modify the plan accordingly, on any or |
|
all three levels. If for instance the original plan called for two |
|
surgeries but during the first operation the surgeon realizes that |
|
all his original long-term goals can be accomplished in this |
|
sitting, the second surgery becomes superfluous |
aThe surgeon must also have a rough idea about what that most optimal outcome can be, both anatomically and functionally (prognosis).
bWhich is the majority of the cases.
cThere are other, less crucial steps, which are not listed here.
dIt can range from the high teens to literally hundreds during a complex trauma case. eThis is rather common in VR surgery, see Table 1.1.
Pearl
Just as a driver who encounters a roadblock or traffic sign that forces him to alter his planned route, a surgeon who finds an unexpected pathology or tissue behavior must change his original plan according to what the new findings dictate.
3.1 Plan (Not Trial and Error) |
21 |
|
|
As in the driving example, the surgical plan cannot be formulated without the surgeon having a clear idea about the desired anatomical outcome of that particular operation. Instead of making ad hoc decisions as pathologies emerge, the surgeon’s tactical decisions are in harmony with the strategy.5 This long-term thinking has multiple advantages (see Table 3.2).
Table 3.2 Long-term vs short-term planning for a patient requiring VR surgery
A 48-year-old male presents with a 6-day history of vision loss; he has 3 D of myopia. He has a macula-off RD with a large tear at the equator inferotemporally. The vitreous is full of pigmented cells, and the tear’s edge is curled
Treatment |
Plan A, focusing on |
Plan B, focusing on the |
Plan C, focusing on the long |
selection |
the short term |
short term |
term |
Rationale for |
Without surgery, the |
Without surgery, the eye |
Without surgery, the eye will |
choosing |
eye will go blind |
will go blind |
go blind. |
that |
There is a risk of PVR, |
There is a risk of PVR; |
The PVR risk is high, surgery |
particular |
but both the RD |
while the RD could |
therefore must be complete |
option |
itself and the risk of |
be taken care of by |
PPV to relieve the current |
|
PVR can be taken |
traditional SB surgery, |
traction and address the |
|
care of by |
the PVR risk requires |
one on the horizon: |
|
traditional SB |
vitreous removal. The |
PVR. For the latter, |
|
surgery. The break |
break is inferior; |
silicone oil is needed. The |
|
has to be lasered. |
therefore adding a SB |
laser must surround the |
|
Gas tamponade is |
increases the chance |
break but also be |
|
needed to |
of success. The break |
circumferential (cerclage) |
|
temporarily cover |
has to be lasered. Gas |
to provide additional |
|
the break |
tamponade is needed |
support. The lens will |
|
|
to temporarily cover |
become cataractous and is |
|
|
the break |
better removed now |
Actual |
A radial SB after |
Vitrectomy, SB |
Cataract extraction with IOL |
treatment |
external drainage of |
(segmental or |
implantation, |
plan |
the subretinal fluid |
circumferential), |
capsulectomy, total |
|
and laser around |
laser, and 30% SF6 |
vitrectomy, endolaser |
|
the break to seal it. |
tamponade |
cerclage, silicone oil |
|
An additional |
|
implantation |
|
encircling band |
|
|
|
against any future |
|
|
|
traction and 0.5 ml |
|
|
|
of pure SF6 for |
|
|
|
tamponade |
|
|
•It requires careful consideration whether an eye that is likely to develop PVR requires primary in-the-bag IOL implantation.
–An eye at high PVR risk may be better off with removal of both lens capsules during the primary surgery, especially if the patient is young (see Sect. 38.5). The implantation of an iris-claw IOL is the last step of the management process (see Sect. 38.6).6
5Another analogy to describe the difference between the two approaches is the example of two football coaches who have the purse to buy new players. One coach buys famous players with the hope that their talent will naturally give birth to a team system; the other one buys players who he thinks will fit his existing coaching philosophy. The second coach should have a higher chance of creating a winning team.
6The implantation is performed months after the silicone oil has been removed.
22 |
3 Fundamental Rules for the VR Surgeon |
|
|
•Suture-constricting a pupil too early makes subsequent VR surgery more difficult (see Sect. 48.1.2).7
•The surgeon should try to anticipate complications such as PVR, which may arise due to the condition itself or as a result of his own intervention. He must try to reduce the risk (prophylactic chorioretinectomy; see Sect. 33.3).
Pearl
A good surgeon is akin to a defensive driver who not only drives carefully but is constantly on alert: keeping watch over all the other drivers around him and trying to anticipate what those drivers may do. A surgeon must never be on autopilot and never do maneuvers as a matter of reflex or custom – there must be a reason for everything he does (or does not do).
•A pseudophakic eye requires a capsulectomy.
–With the probe it is possible to create a capsulectomy regardless of the thickness of the capsule and without the risk of damaging the IOL; in addition, the capsulectomy is precisely of the desired size.
–Performing capsulectomy assures instant and permanently excellent visibility for both patient and ophthalmologist.
–True, YAG laser will probably also allow opening the posterior capsule at any time postoperatively, but the opacified capsule will interfere with visualization until then. The laser also produces a large, permanent floater that may be bothersome to the patient, a consequence that could easily have been avoided by planning ahead.
–Leaving the posterior capsule intact has one, intraoperative, advantage: no risk of IOL fogging during F-A-X (see Sect. 25.2.3.4).
Finally, it must be emphasized that as technology evolves, surgical techniques improve, new materials become available etc., the surgeon must also change. The same condition that a few years ago would have required a certain plan to treat may require a very different plan today.8
Figure 3.1. is an illustrative example of planning. It is from “civilian life,” outside ophthalmology, but it shows the mindset that the VR should develop to replace “instinct” with thinking ahead.
7Another example of long-term thinking is a patient with PDR: the VA is full but the tractional detachment is progressively approaching the fovea. A surgeon with short-term thinking simply hopes that the TRD never progresses that far and defers surgery until the fovea does detach. A surgeon with long-term thinking explains to the patient what is likely to unfold, but also the risks of the surgery, and, with the patient’s informed consent, operates before the fovea detaches.
8One illustrative example: In severely injured eyes I used to preserve the anterior capsule and implant, as the very last step of the treatment process, a sulcus-fixated IOL. In recent years I switched to removing both capsules and implanting an iris-claw IOL (usually possible even if the iris had also been injured and required suturing; see Sect. 38.6).
3.1 Plan (Not Trial and Error) |
23 |
|
|
a
P1
P2
Y 

X 


b
X
X
Y 


Fig. 3.1 Planning to park a car. (a) All cars are parked in a way that reflects their owners’ lack of planning before they had parked their vehicle (peer pressure may also have played a role for those who arrived later). The question is: how will the driver of car X, just arriving, park? This parking lot provides the opportunity to pull through (leaving the car in space P1 instead of P2). Space P1 has numerous advantages: upon leaving, there will be no need to first go in reverse. (b) Backing out not only wastes fuel and wears out the breaks and the gear mechanism earlier, it also makes it impossible for the driver to see, at least initially, whether there is oncoming traffic (such as car Y). If that driver does not pay attention, a crash can easily occur. Furthermore, driver X will be forced to wait until all traffic clears before he can proceed. Parking in space P2, in short, has absolutely no advantage. A VR surgeon, planning ahead, should immediately pull through to space P1
24 |
3 Fundamental Rules for the VR Surgeon |
|
|
3.2Control (as Opposed to Playing Russian Roulette)9
By carefully planning the treatment on levels one and two, it is the surgeon, not chance, that controls the strategic aspects of the treatment. Control intraoperatively10 is also very important; it means that the surgeon has a clear idea about the consequences of each of his maneuvers, how the tissue will (should) react. Instead of “let’s cut into the retina and hope it will not bleed,” control translates to “I will diathermize the retina before cutting into it so that there will be no bleeding.”
Pearl
Ideally, everything that unfolds inside the eye during VR surgery does so because of choice, not chance. Grabbing an EMP in the center and pulling it away from the retina translates into a traction force that acts on the retina at each location where there is adhesion between scar tissue and retina – and the surgeon has no way of knowing where these adhesion points are. By attacking the membrane at its center, the surgeon gives up control over subsequent events and replaces it with hope (centrifugal peeling; see Sect. 32.2.2.5).
3.3Do Not Try to Adapt the Eye to Your Own Preferences
Certain conditions permit, even encourage, a cure by employing against them exactly the same type of surgery, performed in an identical fashion and repeating the same surgical steps; VR pathologies must never be in this category. Each case deserves individual attention and management, on all three levels of planning and executing the plan. Table 3.3 shows the differences between the two approaches.
Trying to force the surgeon’s favorite technique on the eye irrespective of the condition’s unique attributes is wrong and dangerous. The surgeon must adapt to the eye’s condition and not the other way around. He must be able to see the forest, not just the tree, and develop the best possible treatment option in the particular situation. If he is unable or unwilling to modify his approach based on what the eye’s condition demands, he must forego surgery and refer the patient.
3.4The “What, When, How – and Why” Questions
The VR surgeon must always know what he is doing or planning to do, when he plans to do it (timing), and how he intends to do it (tissue tactics). It is equally important for him to always know why he does it, and this is true for all three levels of planning, including every single tissue maneuver during surgery.
9A corollary to this issue is a surgeon who never had binocular vision. In real life it is not a problem: he may not even know this, and no binocularity test is required of a potential VR surgeon. Those who used to have binocular vision but then lost it should not be discouraged either: EAV proves that the human brain is able to cope, even if the learning curve must be respected (see Sect. 17.3).
10Level three, tissue tactics.
- #28.03.202639.38 Mб0The Wills eye manual office and emergency room diagnosis and treatment of eye disease Adam T. Gerstenblith, Michael P. Rabinowitz.chm
- #
- #
- #
- #
- #
- #
- #28.03.202614.01 Кб0[Офтальмология] Jack J. Kanski Джек Дж. Кански - Клиническая офтальмология систематизированный подход [2006, PDF DjVu, RUS] [rutracker-5395873].torrent
- #
- #
- #
